Advanced Therapies Intelligence

Home / 弊社製品 / 商業製品 / Advanced Therapies Intelligence

Stay Ahead in the Rapidly Evolving Advanced Therapies Market

The Advanced Therapy Medicinal Products (ATMP) market is booming, currently valued at $8.5 billion and expected to exceed $20 billion by 2031. In this dynamic market, staying ahead is crucial.

Your Go-To Resource for ATMP Market Insights

Our Advanced Therapies Intelligence dashboard analyzes daily market data, delivering insights, comprehensive evaluations, and expert guidance on the clinical landscape, market trends, regulatory developments, crucial deals, and more.

With our interactive platform, you can customize views, apply filters, and export data, ensuring you access precisely the information you need, when you need it.

Advanced Therapies by the numbers

Analyze over

4,000

drugs in pipeline

Explore results of

7,000

clinical trials

Uncover over

22,000

market events

Be part of

$12B

expected market growth

How Advanced Therapies Intelligence Works

All-In-One Solution

Curated ATMP data is seamlessly integrated with Citeline's insights suite, offering a complete view of drugs in the advanced therapies space

Proprietary Clinical Data

The most reliable comprehensive, and trusted source of pharmaceutical clinical trial and site data

Citeline Portfolio Integration

Advanced Therapies Insights connects directly to the underlying data, sophisticated analytics, and expert human analysis, enabling users to explore the details in depth.

What's included

Competitive Intelligence

Monitor your competition with 14 curated pipeline filters, including drug origin, vector type, cell type, gene editing technology and more

Feasibility

Discover clinical trial sites and investigators with relevant vector or cell technology expertise

Portfolio Strategy

Make quick decisions regarding advanced therapy market opportunities with informed decisions based on reliable data and daily insights

Business Development/Licensing

Benchmark deals and understand potential licensing opportunities in cell and gene therapy

Market Research

Deep assessments of advanced therapies markets, including upcoming catalysts and market insights

Powerful Filters and Search Tools

Pipeline

Evaluate the drug pipeline for a specific disease, covering both approved and inactive drugs.

Trial Overview

Gain insights into the current clinical trial landscape, development stages, and anticipated timelines.

Trial Sites

Discover where clinical trials are conducted, providing essential insights into trial locations and distribution.

Investigators

Review investigator locations and their trial histories, categorized by their level of engagement.

Events

Track market events related to products, indicating potential approval likelihoods.

Catalysts

Monitor upcoming regulatory and clinical events filtered by product, shaping market dynamics.

Insights

Access comprehensive ATMPs articles from leading Citeline news services for a holistic view of the landscape.

Deals

Stay informed on the latest developments in partnership agreements, including deal values and characteristics.

Ask the Analyst

World-class analysis with a personal touch

Our expert analysts deliver in-depth, customized responses to your queries, ensuring you receive the precise insights you need quickly and accurately.

How we help

How can I find exactly what I need with so many subtypes and attributes of ATMPs?

Our custom filtering options address the granularity of the ATMP space, allowing you to narrow down to your specific applications.

How can I distinguish what is real amidst the noise in the data?

Manual curation of data within the Citeline dataset ensures you see the accurate, factual representation of the market.

How can I ensure consistent data replication with each search?

Identical filters applied to every data point ensure reliability and consistency across the platform.

With the rapid pace of this market, how can I stay reliably up to date?

Powered by best-in-class data from Citeline, Advanced Therapies Intelligence evolves dynamically, integrating new data points as they emerge.

Trusted by the American Society of Gene & Cell Therapy (ASGCT)

Q3 2024 marks a potential pivot in the evolution of cell, gene, and RNA therapies. Dealmaking held steady at 101 transactions, but we’re seen a substantial rebound in startup financing. The tripling of seed and Series A rounds to $484 million signals a resurgence of confidence in next-generation CGT technologies.

Coupled with strategic CDMO acquisitions, we’re watching this field mature in real-time, and it’s primed for breakthrough innovations.

弊社の専門家

Biomedtrackerの業界専門家アナリストは、4,000以上のソース（企業、臨床試験、ディール、規制会議）を綿密に監視し、最も重要なイベントを把握して報告することで、より広い視野を持って洞察を得ることができます。弊社のデータとアナリストの洞察を組み合わせることにより、市場で何が生じているか、いつ生じるか、そしてなぜそれがビジネスに重要なのかを知ることができます。Datamonitor Healthcareのレポーターは、主要な疾患、治療法、企業、市場アクセス、市場トレンドについて専門的なカバレッジを提供します。そして、評価の高い弊社のAsk-the-Analystサービスにより、あなたは科学的アナリストに直接アクセスでき、研究や戦略の策定に取り組む中で生じる質問に対応することができます。